A Piergentili - JoVE Visualize

Showing results (1-10 of 21) with videos related to

Pageof 3

Sort By:

Mini Reviews in Medicinal Chemistry|September 11, 2008

Dopamine D5 receptors: a challenge to medicinal chemistsG Giorgioni, A Piergentili, S Ruggieri, et al.

Journal of Autonomic Pharmacology|August 31, 1999

Evaluation of an agonist index: affinity ratio for compounds active on muscarinic cholinergic M2 receptorsS K Tayebati, A Piergentili, D Natale, et al.

Farmaco (Societa Chimica Italiana : 1989)|February 1, 1994

Synthesis and muscarinic receptors affinity of a series of antagonist bivalent ligandsA Piergentili, W Quaglia, S K Tayebati, et al.

Journal of Medicinal Chemistry|September 1, 1990

Synthesis and dopamine receptor affinities of 2-(4-fluoro-3- hydroxyphenyl)ethylamine and N-substituted derivativesF Claudi, M Cardellini, G M Cingolani, et al.

Chemical & Pharmaceutical Bulletin|June 1, 1994

Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodideM Giannella, A Piergentili, M Pigini, et al.

Arzneimittel-Forschung|February 1, 1996

Bicyclic dioxolanes as potential antimuscarinic agentsA Piergentili, P Angeli, M Giannella, et al.

Farmaco (Societa Chimica Italiana : 1989)|October 1, 1993

Synthesis and muscarinic activity of some muscarone analogsC De Micheli, M De Amici, E Grana, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 6, 1997

Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptorsS K Tayebati, M Giannella, A Piergentili, et al.

Bioorganic & Medicinal Chemistry|April 1, 1997

Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic headP Angeli, L Brasili, M L Cingolani, et al.

Journal of Medicinal Chemistry|May 28, 1993

Structure-activity relationships in 1,4-benzodioxan-related compounds. 4. Effect of aryl and alkyl substituents at position 3 on alpha-adrenoreceptor blocking activityW Quaglia, M Pigini, S K Tayebati, et al.

Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:

Pageof 3

Mini Reviews in Medicinal Chemistry|September 11, 2008

Dopamine D5 receptors: a challenge to medicinal chemistsG Giorgioni, A Piergentili, S Ruggieri, et al.

Journal of Autonomic Pharmacology|August 31, 1999

Evaluation of an agonist index: affinity ratio for compounds active on muscarinic cholinergic M2 receptorsS K Tayebati, A Piergentili, D Natale, et al.

Farmaco (Societa Chimica Italiana : 1989)|February 1, 1994

Synthesis and muscarinic receptors affinity of a series of antagonist bivalent ligandsA Piergentili, W Quaglia, S K Tayebati, et al.

Journal of Medicinal Chemistry|September 1, 1990

Synthesis and dopamine receptor affinities of 2-(4-fluoro-3- hydroxyphenyl)ethylamine and N-substituted derivativesF Claudi, M Cardellini, G M Cingolani, et al.

Chemical & Pharmaceutical Bulletin|June 1, 1994

Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodideM Giannella, A Piergentili, M Pigini, et al.

Arzneimittel-Forschung|February 1, 1996

Bicyclic dioxolanes as potential antimuscarinic agentsA Piergentili, P Angeli, M Giannella, et al.

Farmaco (Societa Chimica Italiana : 1989)|October 1, 1993

Synthesis and muscarinic activity of some muscarone analogsC De Micheli, M De Amici, E Grana, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 6, 1997

Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptorsS K Tayebati, M Giannella, A Piergentili, et al.

Bioorganic & Medicinal Chemistry|April 1, 1997

Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic headP Angeli, L Brasili, M L Cingolani, et al.

Journal of Medicinal Chemistry|May 28, 1993

Structure-activity relationships in 1,4-benzodioxan-related compounds. 4. Effect of aryl and alkyl substituents at position 3 on alpha-adrenoreceptor blocking activityW Quaglia, M Pigini, S K Tayebati, et al.

Pageof 3